Imclone systems (IMCL) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Imclone systems (IMCL)

An SI Board Since October 1996

Posts	SubjectMarks	Bans	Symbol
2515	89	0	IMCL

Emcee: Deeber	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1640	FWIW... 7:36AM Imclone Sys (IMCL) 45.50: CNBC reports that there has been very	caly	-	8/20/2001
1639	Somebody is walking this up in a straght line today. More rumors of a buy-in on	613	-	8/17/2001
1638	Sometimes big companies with real income become targets for big legal cases if t	Oak Tree	-	7/31/2001
1637	Probably also because insurance is more private here. I knew that US was by far	613	-	7/30/2001
1636	Here's an article that indicates that the US market for Pharmaceuticals is m	Zirdu	-	7/30/2001
1635	I don't know for sure, but I think the US market for most drugs is bigger th	Zirdu	-	7/30/2001
1634	Is the US market bigger than all of Europe?	613	-	7/30/2001
1633	<<Interestingly Merck, a partner of IMCL, is developing a competing produc	Zirdu	-	7/30/2001
1632	You probably know that there are also a number of other immune therapies being d	Oak Tree	-	7/29/2001
1631	Merck has the rights to C225 in Europe. Not sure how much of that goes to IMCL.	613	-	7/29/2001
1630	I found the source of the estimate that C225 could be worth 400M per year, its M	Oak Tree	-	7/29/2001
1629	Bottom line is that I tend to agree with you that IMCL seems 'farily priced&	613	-	7/27/2001
1628	Hi Oak Tree, <<Updates on the Treatment of Non-Small Cell Lung Cancer by	EdR	-	7/26/2001
1627	Cancer centers have invited speakers each week that fly in. Todays speaker was f	Oak Tree	-	7/26/2001
1626	'grand rounds' - what's that? Rumor has it that results in early te	613	-	7/26/2001
1625	Went to grand rounds today and there was a guy discussing the various chemothera	Oak Tree	-	7/26/2001
1624	Article on Merck states their estimate of revenue from C225 is $400M. Also, of	613	-	7/25/2001
1623	I bought back my imcl today between 41.55 and 43.15	Oak Tree	-	7/24/2001
1622	Your math is off. 50K patients * (50K or 100K) = 2.5B to 5B. The 50K patient e	613	-	7/24/2001
1621	I guess if you start with the assumption of 3 years of market control and you ha	Oak Tree	-	7/23/2001
1620	Check the posts from pharmainvestor1 and neblo on Yahoo. Basic argument seems t	613	-	7/23/2001
1619	Thanks for bringing my attention to IMCL. C225 was very exciting a few months ba	Oak Tree	-	7/23/2001
1618	ImClone Systems Achieves $2 Million Manufacturing-Related Milestone Under IMC-C2	613	-	7/16/2001
1617	I've been trying to figure out how to value this company. Some of the best	613	-	7/13/2001
1616	Rumor of the day * JAGFN RUMORS (IMCL ,BMY ) [JAGrumors, 40 words] Imclone Sys	CatLady	-	7/13/2001

Go to reply# or date (mm/dd/yy):